Inicio › Trastorno bipolar › Georgia
Ensayos clínicos de Trastorno bipolar en Georgia
9 estudios sobre Trastorno bipolar buscan participantes en Georgia.
Ciudades en Georgia
Texto oficial del estudio (inglés)
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- CenExeli Research LLC, Atlanta
- Atlanta Center for Medical Research, Atlanta
- CenExeli Research LLC 1, Savannah
ReclutandoFase 3
Edades de 5 a 17 · Todos los sexos · Actualizado el 25 sept 2026 · NCT06229210Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
- CenExeli Research LLC, Atlanta
- CenExeli Research LLC 1, Savannah
ReclutandoFase 3
Edades de 10 a 17 · Todos los sexos · Actualizado el 25 sept 2026 · NCT06372964A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)
- Atlanta Center for Medical Research, Atlanta
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07286175A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Augusta
ReclutandoFase 4
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 sept 2026 · NCT07105111A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
- Synexus Clinical Research, Inc., Atlanta
- Atlanta Center for Medical Research, Atlanta
- CenExel iResearch, Decatur
- y 1 más
ReclutandoFase 3
Edades de 18 a 74 · Todos los sexos · Actualizado el 2 sept 2026 · NCT07172516A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
- Georgia Psychiatric Consultants and Advanced Discovery Research /ID# 279438, Atlanta
ReclutandoFase 2
Edades de 18 a 65 · Todos los sexos · Actualizado el 14 ago 2026 · NCT06696755Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
- Bioxcel Clinical Research Site, Decatur
ReclutandoFase 1
Edades de 10 a 17 · Todos los sexos · Actualizado el 11 ago 2026 · NCT05025605A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
- CenExel iResearch, LLC, Savannah
ReclutandoFase 3
Edades de 18 a 65 · Todos los sexos · Actualizado el 23 jun 2026 · NCT07140913Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- University of Georgia, Athens
ReclutandoEstudio observacional
Edades de 18 a 40 · Todos los sexos · Actualizado el 10 mar 2026 · NCT06740383De ClinicalTrials.gov, datos obtenidos el 3 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.